JUN 09, 2020 8:31 AM PDT

Psychedelic DMT Improves Wellbeing in 89% of People

WRITTEN BY: Annie Lennon

DMT is a powerful psychedelic drug known to produce visions involving 'other beings' like elves, aliens, and deities. Researchers from Johns Hopkins School of Medicine have surveyed over 2,500 people who have taken the drug to understand the impact these experiences had on them. 

Most of the participants had used DMT (N, N-Dimethyltryptamine) around a dozen times. The study excluded people who consumed ayahuasca and those whose DMT experiences may have been influenced by other drugs taken at the same time. 

In the end, the researchers found that 99% of those who encountered other beings during their DMT experiences had an emotional response. While 59% of participants felt love, 65% felt joy, and 63% felt trust. A minority felt negative emotions, including sadness (13%) and disgust (4%). 

At the same time, 81% of respondents said that their encounters felt 'more real than reality.' Around 75% reported believing that the beings they encountered were real, but existed in another dimension or reality, while only 9% thought the experiences existed 'completely within themselves.' 

"Additionally, approximately one-third (36%) of respondents reported that before the encounter their belief system included a belief in ultimate reality, higher power, God, or universal divinity, but a significantly larger percentage (58%) of respondents reported this belief system after the encounter." say the researchers. 

Meanwhile, 60% of the survey respondents thought that DMT "produced a desirable alteration in their conception of reality, whereas only 1% indicated an undesirable alteration in their conception of reality."

Adding to this, 89% of participants said the encounters led to lasting improvements in their wellbeing and life satisfaction. As such, the researchers think that the drug may hold promise as a therapy for people with mood and behavioral problems such as depression and addiction, in years to come. 

Although an observational study not conducted under lab conditions, the researchers hope that these early findings may open further research avenues for the drug.



Sources: Big Think, New Atlas

About the Author
  • Science writer with a keen interest in behavioral biology, consciousness medicine and technology. Her current focus is how the interplay of these fields can create meaningful interactions, products and environments.
You May Also Like
JAN 25, 2021
Cancer
Combining Radiotherapy and Immunotherapy in Liver Cancer
JAN 25, 2021
Combining Radiotherapy and Immunotherapy in Liver Cancer
The dream of a magic bullet drug plagues the mind of scientists, doctors, and patients. The truth is some diseases are j ...
JAN 24, 2021
Drug Discovery & Development
Finding New Cancer Drugs
JAN 24, 2021
Finding New Cancer Drugs
Cells in our body share the same genes. But how those genes are expressed can dictate the fate of a cell. For ...
MAR 02, 2021
Coronavirus
Vitamin B6 May Reduce the Risk of Severe COVID-19
MAR 02, 2021
Vitamin B6 May Reduce the Risk of Severe COVID-19
Scientists are trying to learn more about whether any nutrients, like vitamins C, D, and now B6, can provide some protec ...
APR 12, 2021
Drug Discovery & Development
Epidural Use Not Linked To Autism
APR 12, 2021
Epidural Use Not Linked To Autism
Epidurals are a form of pain relief during childbirth and is used by more than half of all women in labor. Many women wh ...
MAY 13, 2021
Health & Medicine
New Peptide Allows Cannabis to Fight Pain With Fewer Side Effects
MAY 13, 2021
New Peptide Allows Cannabis to Fight Pain With Fewer Side Effects
THC-rich cannabis is well known to bring relief for some chronic pain sufferers. But the downside, off putting for many ...
MAY 15, 2021
Drug Discovery & Development
New Drug Blocks Critical Step in Malaria Life Cycle
MAY 15, 2021
New Drug Blocks Critical Step in Malaria Life Cycle
According to the World Health Organization (WHO), in 2019, there were approximately 229 million cases of malaria around ...
Loading Comments...